Associations between IBS, IBD and the risk of Insomnia: An Observational Analysis and Genome-wide Interaction Study

Authors:

Abstract
Background: Irritable bowel syndrome (IBS) and inflammatory bowel diseases (IBD) were reported to be associated with mental disorders. But limited efforts were made to investigate the relationship between IBS/IBD and the risk of insomnia, especially from genetic perspective. Methods: Based on the UK Biobank cohort, we first calculated the polygenic risk scores (PRS) of IBS and IBD. Linear regression analyses were conducted to evaluate the association of IBS/IBD PRS with 7 sleep-related traits (N = 285,538-376,545), such as insomnia, short sleep. Genome-wide interaction study (GWIS) was performed to test the interacting effects of SNP × IBS PRS/Crohn's disease (CD) PRS on the risk of insomnia. Linkage disequilibrium score regression (LDSC) was performed to evaluate the genetic correlation between IBS/IBD and sleep-related traits by using genome-wide association study (GWAS) summary data of IBS (N = 29,524), IBD (CD: N = 5,956; UC: N = 6,968) and sleep-related traits (N = 1,331,010). Results: For IBS, observational analyses showed that IBS PRS was significantly associated with insomnia (P = 2.37×10-2), short sleep (P = 2.49×10-2) and healthy sleep score (P = 9.95×10-4). LDSC identified significant genetic correlation of IBS and sleep-related traits, such as insomnia (P = 1.12×10-23). GWIS observed significant interaction effects of LTBP1 ´ IBS PRS for insomnia (rs184718843, P = 6.04×10-9). For IBD, we found an association between CD PRS and insomnia (P = 3.57×10-2). LDSC detected significant genetic correlation between CD and dozing (P = 1.20×10-3). For CD PRS, GWIS detected several suggestive interaction signals for insomnia, such as ANKRD30A (rs551207458, P = 7.10×10-7). Conclusion: Our results suggested that IBS and IBD were functionally related to insomnia, and reported several candidate genes interacting with IBS/IBD PRS for insomnia.